{"DataElement":{"publicId":"64315","version":"3","preferredName":"Specimen Inflammation Change Type","preferredDefinition":"a qualitative estimate by percent indicating changes in a tissue specimen due to inflammation.","longName":"SPEC_INFLM_CHG_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2009355","version":"3","preferredName":"Specimen Inflammation Change","preferredDefinition":"related to evidence of alteration in a sample of tissue or blood collected for medical research which indicates a response of redness or swelling resulting from injury, disease or treatment.","longName":"SPEC_INFLM_CHG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2241613","version":"1","preferredName":"Specimen","preferredDefinition":"Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-2242-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2452698","version":"1","preferredName":"Inflammation Change","preferredDefinition":"A response of redness, swelling, pain, and a feeling of heat in certain areas that is meant to protect tissues affected by injury or disease.:alteration or modification.","longName":"C3137:C25446","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-67EA-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-23","modifiedBy":"ONEDATA","dateModified":"2006-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D052842-7E4C-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO 11179 compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015462","version":"3","preferredName":"Specimen Inflammation Change Type","preferredDefinition":"a qualitative estimate by percent indicating changes in a tissue specimen due to inflammation.","longName":"SPEC_INFLM_CHG_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"10-75% inflammatory cells","valueDescription":"SPECIMEN OR SAMPLE IS COMPRISED OF 10% TO 75% (INCLUSIVE) INFLAMMATORY CELLS","ValueMeaning":{"publicId":"2560085","version":"1","preferredName":"SPECIMEN OR SAMPLE IS COMPRISED OF 10% TO 75% (INCLUSIVE) INFLAMMATORY CELLS","longName":"2560085","preferredDefinition":"SPECIMEN OR SAMPLE IS COMPRISED OF 10% TO 75% (INCLUSIVE) INFLAMMATORY CELLS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7C2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D7CD6EC-0394-2B1E-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-23","modifiedBy":"ONEDATA","dateModified":"2006-02-23","deletedIndicator":"No"},{"value":"<10% inflammatory cells","valueDescription":"SPECIMEN OR SAMPLE IS COMPRISED OF LESS THAN 10% INFLAMMATORY CELLS","ValueMeaning":{"publicId":"2560086","version":"1","preferredName":"SPECIMEN OR SAMPLE IS COMPRISED OF LESS THAN 10% INFLAMMATORY CELLS","longName":"2560086","preferredDefinition":"SPECIMEN OR SAMPLE IS COMPRISED OF LESS THAN 10% INFLAMMATORY CELLS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7C3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D7CD6EC-0395-2B1E-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-23","modifiedBy":"ONEDATA","dateModified":"2006-02-23","deletedIndicator":"No"},{"value":">75% inflammatory cells","valueDescription":"SPECIMEN OR SAMPLE IS COMPRISED OF MORE THAN 75% INFLAMMATORY CELLS","ValueMeaning":{"publicId":"2560087","version":"1","preferredName":"SPECIMEN OR SAMPLE IS COMPRISED OF MORE THAN 75% INFLAMMATORY CELLS","longName":"2560087","preferredDefinition":"SPECIMEN OR SAMPLE IS COMPRISED OF MORE THAN 75% INFLAMMATORY CELLS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7C4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D7CD6EC-0396-2B1E-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-23","modifiedBy":"ONEDATA","dateModified":"2006-02-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D7CD6EC-0380-2B1E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-23","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":"updated for ISO 11179 compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812017","version":"1","longName":"Phase II Lung Cancer","context":"CTEP"},{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"},{"publicId":"2811962","version":"1","longName":"Response","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811936","version":"1","longName":"Pathology Lung","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Inflammatory Change","type":"Preferred Question Text","description":"Inflammatory Change","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Inflammatory Change","url":null,"context":"CTEP"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0D7CD42A-E582-27A0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-23","modifiedBy":"REEVESD","dateModified":"2011-04-05","changeDescription":"updated for ISO 11179 compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}